The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to
NHS figures.
Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia
(also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 - a notable 18 per cent increase or nearly 550,000 people.
Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023.
People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and
cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.
Long waits for an ambulance or surgery led to the death of 112 people, and nearly 8,000 more people suffered harm while waiting for help in England last year.
The data from NHS England, obtained by The Guardian, show that patient deaths arising directly from care delays have risen more than fivefold over the last
three years.
In 2019, there were 21 patient deaths due to NHS care delays, and 96 people suffered "severe harm" as compared to 152 last year.
Adult mental health care was mostly affected with 471 patients experiencing harm due to delays, followed by childbirth care (253), eye problems (221), and
trauma and general surgery (207).
There has been increase of 97 percent in the overall number of people suffering some degree of harm, from 3,979 in 2019 to 7,856 in 2022.
Dementia is an extremely deceptive disease that develops slowly and may go unnoticed in people, said NHS mental health director Claire Murdoch, while
urging people to look out for the vital warning signs of this condition among family and friends over Christmas.
Common early symptoms of dementia may include emotional change, forgetfulness, difficulty concentrating, struggling to follow a conversation or find the right word,
being confused about time and place, the health service has cautioned.
An increasing number of people have been diagnosed with dementia in England since the start of the pandemic, following a drive by the NHS England to increase
diagnosis rates.
In November 2023, NHS staff diagnosed 463,797 people aged over 65 with dementia, up more than 41,000 compared to the same period last year, according to the
figures revealed by the health service.
Well Pharmacy is urging those eligible to take up the offer of a further Covid booster jab this spring.
Adults aged 75 years and over and anyone over 5 years old and are immunosuppressed - such as those who are undergoing chemotherapy or have had an organ
transplant - are entitled to have a further Covid booster jab from mid-April, said one of the UK's largest community pharmacy chains.
Taking part in the vaccination programme again, Well Pharmacy is encouraging people to book another booster as soon as they are contacted by the NHS - which
should be at least six months after their previous booster.
The national booking site for those eligible opens this week.
The jabs have been updated since the vaccines were introduced to now target newer strains of Covid-19, Well said in a press release issued on Wednesday, 5 April.
Thousands of people are still testing positive for Covid each week according to Government data, and - while hospitalisations are down - a large number of people
are still being hospitalised with Covid, so getting jabbed is as important as ever.
And the Joint Committee on Vaccination and Immunisation (JCVI) recently confirmed that hospital admissions last autumn highlighted that the risk of becoming
seriously ill from coronavirus was noticeably higher in people over 75.
NHS England has expanded its national bowel screening programme to people aged 54 so that cancers can be detected at an earlier stage when they are easier to
treat.
As part of the expansion, the health service would be sending a home-testing kit for bowel cancer, known as the Faecal Immunochemical Test (FIT), to thousands more
people in the North West.
Those who are eligible (aged 54 and over) will now automatically receive the kit every two years by post, enabling them to self-check for blood in stool samples,
which can be a sign of bowel cancer.
With the expansion of the NHS Bowel Cancer Screening Programme to people aged 54 years, an additional 830,000 people in England will now be eligible for the
screening test.
The number of people living to be 100 or more increased by 3.7 per cent in England and Wales in 2022, compared to the previous year, according to new
figures from the Office for National Statistics (ONS).
ONS data also revealed that the number of centenarians in the UK has more than doubled in the last two decades.
Wales has more centenarians (27 people per 100,000 aged 100 or over) than England (25 people per 100,000).
It's good news that more people are living into their second century, but it also means that we may need to rethink our health plans for a longer future, a leading
testing expert has suggested.
Commode chairs are best suited for people who cannot use a regular toilet. The chairs enable patients who have limited mobility due to an accident or any medical condition to use the toilet with ease. The chair allows the patient to use the toilet without causing discomfort to the legs and back. The chair can be used by people who are restricted to a bed or wheelchair. A commode chair is a useful mobility for people of any age who are recovering from injury or surgery. The chair offers a reasonable level of independence to the user; a handy device to be presented to someone who needs it and for whom care. Commode Wheelchairs which are specially designed for aged and physically challenged people. These wheelchairs can be used for indoor toilet purposes. Fabricated using quality raw material, these wheelchairs are suitable for domestic and hospital purpose.
There are two types for handicapped and disability product like Commode Wheelchair-
Commode Wheelchair Rainbow 6
Commode Wheelchair Rainbow 7
Commode Wheelchair Rainbow 6:
Karma commode wheelchair rainbow 6 comes with lot of exiting features for elderly or physically challenged person who want commode in wheelchair. Karma Rainbow 6 has single seat with center cut commode having cushion cover on top and removable pan or plastic commode seat with pot.
Commode Wheelchair Rainbow 6 Features:
Frame Material : M.S.Chrome Plated
Single Seat with center cut commode
Both Option Available In Single Seat
Plastic Commode Seat With Pot.
Cushioned Top Cover
Square Pan Commode Pan
Removable Pan
Commode Wheelchair Rainbow 6 Measurements:
Frame Style : Foldable
Open Position Wheel To Wheel Width In : 26" (Inches)
Seat Width : 18" (Inches)
Total Width in Closing Position : 11" (Inches)
Rear Wheel Size : 24" (Inches)
Front Wheel Size : 8" (Inches)
Seat to Floor Height : 19" (Inches)
Seat Depth : 18" (Inches)
Total Height : 34" (Inches)
Max User Weight Capacity : 110 (kgs)
This commode chair is somewhat heavy but, it is very strong and serves the purpose very well.We are a foremost importer & supplier of a quality assured range Commode Chairs. These are sourced from reliable partners based across the country in order to assure optimum quality & reliability. Commode chairs are available in different models & specifications to meet the exact demands of clients. made of high grade material, these are known for salient attributes like durability, robust construction and easy to handle.
We further offer these to clients at economical prices and within the stipulated time period.it very effective and useful. It doesn't seem to be made of a material which will rust away, so it can be used as bathing chair too.It is easy and convenient to use.
It is fold able and portable designIt can be used for a long period of time.It is made of high quality material and is durable.It is clean, compact and light-weight equipment.
This Commode Chair is specially designed for old aged people or who has some sort of disability to help and encourage them in toilet activities. The Commode Chair has adjustable height which gives comfort to the people who have a problem in squatting due to their back and knee pains. A commode stool is most essential and necessary equipment in a household where old age citizens reside. Elderly people usually are suffering from joint aches, and face difficulties in using Indian style toilets. This commode stool is specially designed for that kind of people.
Features
* Adjustable backside height.
* Durable plastic snap on seat and lid.
* Comfortable.
* Easy to use.
* Gives effective result.
Commode Wheelchair are best suited for people who cannot use a regular toilet. The Wheelchair enable patients who have limited mobility due to an accident or any medical condition to use the toilet with ease. The Wheelchair allows the patient to use the toilet without causing discomfort to the legs and back. The Wheelchair can be used by people who are restricted to a bed.
What are the advantages?
The Wheelchair are convenient and portable with some models available fitted with wheels.Commode Wheelchair can be setup next to the bedside, in the toilet, or even as a frame placed over a regular toilet.
The Wheelchair are fairly comfortable and are equipped with back and arm rests that can be removed whenever needed. The removable back option allows the chair to be used as frame for a regular toilet. Patients who are recuperating from surgery and have difficulty in standing up can easily shift from the wheelchair to the Commode Wheelchair without requiring any support.
The Wheelchair can be modeled to suit the user's requirements. The chairs come in a variety of shapes and sizes for people of all ages. Bariatric commode chairs are designed for use by people who are over 280-300 pounds.
Buy online commode wheelchair for handicapped and disabled at lowest price and cheap cost in india from wheelchair india online shopping store of commode wheelchair manufacturer, distributor, dealer and supplier of variety of Karma Commode Wheelchair at low price in india
Durable and easy to maintain
Commode Wheelchair are quite durable especially those made from a combination of metal and plastic. Ideally the legs and arms of the chair should have a metal base while the rest of the body could be made from plastic.
The Wheelchair if it's to be used in the shower can be fitted with a mesh covering that not only protects the chair from mold but also dries quickly. A commode Wheelchair built from durable plastic material is easier to clean using a disinfecta
Easily fold-able frame provides convenience to carry.
Ideal for storage in small living areas.
Brand Imported.
Fold-able Stool like Frame, ideal for storage in toilets with seat width of 15-inch without bucket.
A commode is a great alternative to using the toilet. People who have difficulty getting to the toilet or spend long periods of time in bed can benefit from using a commode.Commodes are portable toilets that can be used beside the bed.These are designed and manufactured in accordance with international quality norms & standards, using high-grade raw material. All our products are widely used in homes, hospitals, nursing homes and clinics. In addition to this, we provide customization as per the specifications laid down by the customers.It has a comfortable padded seat that can be wiped clean and used for support whilst getting dressed.
Features:
High durability
Easily portable
Light weight
Commode Chair-
These chairs are highly demanded in hospitals and homes for patients or old age people who cannot walk by themselves. Our Portable Commode Chair is made from premium quality materials with the help of advance technology. Moreover, we offer these chairs at economical prices for our clients.
Our Range starts from simple commode stool to economy chairs and extends upto more sturdier and durable chrome plated and light weight aluminum models with options of folding and height adjustment and with or without castors / seat cover.
Commode chairs can be helpful for:
People with dementia and incontinence.
Anyone at risk of falling overnight whilst getting to the toilet.
People who are short of breath or unsteady on their feet.
The National Institute for Health and Care Excellence (NICE) has recommended first new treatment - 'romosozumab' for osteoporosis for over a decade.
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment - romosozumab - after
NICE published the final draft guidance.
Over 20,000 people could be eligible for the treatment according to the company. Clinical trial evidence showed that romosozumab (also known as EVENITY and made by
UCB) followed by alendronic acid is more effective at reducing the risk of fractures than alendronic acid alone.
Osteoporosis is a disease that causes bones to become thin and fragile. Many people with osteoporosis show no symptoms, but they may be at increased risk of fracture.
Osteoporosis leads to nearly 9 million fractures around the world each year, and over 300,000 people per year attend hospitals in the UK with fractures caused by
osteoporosis.
NHS chief executive Amanda Pritchard joined over 17 million people in England by taking her Covid-19 booster dose on Monday (December 6) whilst encouraging people to take their top-up jab.
The NHS boss got a dose in each arm as she also received her flu vaccine from pharmacist Bhaveen Patel at the Junction Pharmacy in Brixton.
Pritchard later posted a video on Twitter, thanking the team in the south London community pharmacy.
Ahead of the first anniversary of the NHS delivering the first Covid-19 vaccine in the world on Wednesday (December 8), Pritchard thanked the "incredible efforts" of NHS staff and volunteers who worked hard to protect millions of people.
Almost 100 million jabs have been delivered in England since December 8, 2020, including over 17 million booster vaccines.
Expressing her delight after taking the booster dose, Pritchard said: "The booster jab was quick, easy and I now have extra protection against the virus."
National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal
immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July).
Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were
immediately referred on the suspected cancer pathway.
The new draft guidance will now see everyone receive a FIT.
A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with
10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation.
Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer.
The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer.
The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist.
The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent
referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.
More than three quarters of British people, who have suffered persistent ill health following a Covid-19 infection, have had to cut back or change the work
they do, according to a survey on the impact of long Covid published on Wednesday (November 9).
In the survey of 1,002 people, conducted by market research company Censuswide, some 98 per cent of long Covid sufferers said the condition had limited their ability
to work, with 78 per cent needing to cut back or change their work and 19 having ceased work altogether.
Long Covid, a collection of symptoms ranging from pain and heart palpitations to insomnia and brain fog, can last for many months after initial infection.
Britain's most recent official labour market data showed that a record proportion of people classified as "economically inactive" - neither working nor looking for a
job - were suffering from long-term sickness. In absolute terms, the number of working-age people who are long-term sick has risen by 378,000 since early 2020.
The number of people suffering from addiction is at an all time high, with more people seeking treatment across the USA due to the fentanyl crisis, but new
studies have shown that addiction drugs may not only be able to aid those suffering from the deadly disease, but also aid people suffering from long COVID.
While there has long been research underway to find a cure for the likes of alcoholism and drug addiction, it turns out naltrexone, a drug used in the addiction
treatment space, is helping people who have been suffering from headaches, seizures and fatigue as a result of long COVID.
According to Dr. Paul Valbuena at The River Source, an Arizona drug rehab, naltrexone is typically used by rehab centers and prescribed to patients suffering from
addiction to reduce cravings and the feeling of euphoria associated with substance use disorder, giving patients clarity and focus to concentrate on recovery.
Thanks to a recent report, that has also been revealed to be the case for those suffering with long COVID too, with Lauren Nichols, a long COVID sufferer from Chicago
being prescribed the drug by her doctor.
She found that the drug helped quell her seizures and headaches, alowing her to think clearly and get on with her life as normal. It's been a similar story for other
patients too, and has marked a major breakthrough in the bid to help those who are still suffering in the aftermath of the pandemic.
There is no doubt that the pandemic has changed the way healthcare professionals work within the primary care setting. The advent of Covid-19 meant that we all
had to rapidly modify the way we supported and met the needs of patients, some of whom saw the services they usually took for granted, virtually cease overnight.
There are around 15 million people in England living with long-term health conditions including asthma. These people have the greatest healthcare needs of the whole
population with 50 per cent of all GP appointments and 70 per cent of all bed days taken by this cohort of patients, and their treatment and care absorbing 70 per
cent of acute and primary care budgets in England.
This situation isn't going to improve any time soon. In the past, most people had a single condition, today multi-morbidity is becoming the norm. At the start of the
pandemic, the Royal College of General Practice and British Medical Association issued guidance to practices on prioritising workload. This included the importance
of maintaining long-term condition reviews in asthma, COPD and diabetes, along with appropriate transition of at-risk warfarin patients. These reviews were deemed as
essential workstreams for patients considered to be at high risk.
Traditionally, the unique skills set of a pharmacist has meant that we have played a major role in supporting these patients. I work with a team of over 90 clinical
pharmacists who, in partnership with individual practices, PCNs, CCGs and STPs, help with the long-term management of people with chronic conditions. But the onset
of Covid-19 meant that we now had to plug a potential gap in service provision, and quickly.
Panadol launched a new purpose-led brand idea as part of a multi-channel campaign across Great Britain and Ireland. With nine out of 10 people suffering
"everyday pain" and 65% of people saying they can't be happy when they are in pain[1], globally, the campaign reiterates the brand's commitment to holistic pain
management by focusing on the acute pain recovery journey.
Rooted in deep consumer understanding, the campaign idea celebrates that never-talked-about moment of realisation when you start to feel the release from pain.
The new brand idea will bring to life the emotional transformation that those suffering from acute pain undergo, emphasising the role that Panadol can play in
alleviating their pain.
The Panadol campaign follows a period of strong sales growth for the brand, outperforming the category's own expansion by more than double[2].
This has been driven by shoppers who are searching for fast and effective pain relief products, such as Panadol's hero variants, including Panadol Extra Advance
Tablets (paracetamol, caffeine), which has seen its growth almost doubled[3], as well as Panadol Advance Tablets (paracetamol) and Panadol Extra Advance Tablets.
Monica Michalopoulou, GBI Marketing Director, said: "After two years of pandemic restrictions, now more than ever, people want to get back to their normal lives
and to the people they love. But with pain preventing many of us from connecting with those we love or from doing the things we enjoy the most, we want to help
consumers by understanding their pain journey and reassuring them on the treatments we can provide. This "Release" moment is so important for pain sufferers, and we hope our new brand campaign can shine a light on the role that Panadol can play in pain relief".
The new data from NHS England has revealed that more than 100,000 patients were treated for minor illness by their high street pharmacist in just one month.
According to new NHS figures, in June, 118,123 people with minor illnesses such as a sore throat or constipation, or those in need of medicine urgently, received
a same-day consultation with their local pharmacist after calling NHS 111 or their GP practice - an increase of more than four-fifths (83%) on the number in the same
month last year (64,512).
The data comes alongside expanded roles for community pharmacies ahead of winter, announced at the NHS England board meeting today.
"From this week, NHS 111 online can directly refer people to their high street pharmacist for a same-day consultation, rather than patients needing to call the
phone line," said NHS England.
Amanda Pritchard, NHS chief executive, said: "Our local pharmacies ensure hundreds of thousands of people every week get the support and medication they need and
today's figures show that in just one month, over 100,000 patients have also had consultations with their local pharmacist for minor illnesses - this means patients
are getting the care they need quickly but also in a convenient way that can fit in with their busy lives.
Well Pharmacy is offering free blood pressure checks in all its branches across England to raise awareness of the dangers posed by hypertension.
The leading independent pharmacy chain is inviting people to #thebigsqueeze in conjunction with May Measurement Month and World Hypertension Day (May 17) by
inviting them to get a free blood pressure check and to learn more on the importance of understanding hypertension.
George Sandhu, deputy superintendent pharmacist at Well Pharmacy said: "May Measurement Month is a global blood pressure screening awareness campaign. The aim is
to raise awareness of the dangers posed by elevated BP and hypertension. May 17 is World Hypertension Day, and a perfect time to take control and get your blood
pressure checked.
"We are delighted to be supporting this campaign. Hypertension (more commonly known as high blood pressure) can cause a range of health issues. Worryingly, it often
comes with no symptoms, which is why it is vital to know if your blood pressure is higher people don't have any symptoms of high blood pressure so having their blood
pressure checked is the only way to find out.
"People can come into any of our Well Pharmacies across England and have their blood pressure checked. The theme for 2023 is Measure Your Blood Pressure Accurately,
Control It, Live Longer - and knowing your number is one of the most important things people can do.
Well Pharmacy has announced that the bookings for the flu vaccine later this year are now open.
This is earlier than usual and gives people the best chance to prepare for flu season, knowing that their vaccine can be done as soon as possible when the season
starts.
Appointments for the flu jab can be booked for a date later this year. The price for the private service is £17.99, but jabs for people eligible on the NHS will be
free.
Well Pharmacy stresses that it is important that people remain flu savvy and protect themselves and others.
Free NHS flu jabs will be available to those over 65 in England and Wales currently, and to people eligible in a clinical risk group.